4-Methylmorpholine → HCID 23521492, compound

HRID 392515Notes

Reaction equation

HRID 392515 reaction equation
[Br:1][C:2]1[CH:3]=[C:4]2[CH2:12][CH2:11][C:10]3[CH:13]=[C:14]([Cl:17])[CH:15]=[CH:16][C:9]=3[CH:8]([N:18]3[CH2:23][CH2:22][N:21]([C:24]([O:26][C:27]([CH3:30])([CH3:29])[CH3:28])=[O:25])[C@@H:20]([C:31]([OH:33])=O)[CH2:19]3)[C:5]2=[N:6][CH:7]=1.Cl.CN(C)[CH2:37][CH2:38][CH2:39][N:40]=[C:41]=[N:42][CH2:43][CH3:44].O[N:47]1[C:51]2C=[CH:53][CH:54]=[CH:55][C:50]=2N=N1.CN1CCOCC1>CN(C=O)C>[Br:1][C:2]1[CH:3]=[C:4]2[CH2:12][CH2:11][C:10]3[CH:13]=[C:14]([Cl:17])[CH:15]=[CH:16][C:9]=3[CH:8]([N:18]3[CH2:23][CH2:22][N:21]([C:24]([O:26][C:27]([CH3:28])([CH3:30])[CH3:29])=[O:25])[C@@H:20]([C:31]([N:47]4[CH2:53][CH2:54][CH2:55][CH2:50][CH:51]4[CH2:37][CH2:38][CH2:39][N:40]4[CH:44]=[CH:43][N:42]=[CH:41]4)=[O:33])[CH2:19]3)[C:5]2=[N:6][CH:7]=1

Participants

6

Reactant 4

HCID 79724-MethylmorpholineHCID 757711-HydroxybenzotriazoleHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 23521496HCID 23521496, compound

Product 1

HCID 23521492HCID 23521492, compound

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Procedure

1,1-dimethylethyl 4-(3-bromo-8-chloro-6,11-dihydro-5H-benzo[5,6] cyclohepta[ 1,2-b]pyridin-11-yl)-2(R)-carboxy-1-piperazinecarboxylate (0.7225 g, 1.3 mmoles) (prepared as described in Preparative Example 6), the title compound from Preparative Example 8, Step B (0.3382 g, 1.7 mmoles), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.3354 g, 1.7 mmoles), 1-hydroxybenzotriazole (0.2364 g, 1.7 mmoles) and 4-methylmorpholine (0.192 mL, 1.7 mmoles) were dissolved in anhydrous DMF (3 mL) and the mixture was stirred under argon at 25° C. for 319 h. The solution was evaporated to dryness and the residue was taken up in dichloromethane and washed with saturated aqueous sodium bicarbonate, water, dried (MgSO4), filtered and evaporated to dryness. The residue was chromatographed on silica gel using 3% (10% conc. NH4OH in methanol)-dichloromethane as the eluant to give the partially purified title compounds. The appropriate fractions were rechromatographed using 1.5% (10% conc. NH4OH-methanol)-dichloromethane as the eluant to give title compound as a mixture of 4 diastereoisomers (0.3718 g, 39%): FABMS: m/z 711.4 (MH+); δH (CDCl3) 1.39 (9H, s, CH3), 6.91, 7.08, 7.13, 7.17, 7.56, 7.67 (Ar—H), 6.97 (1H, s, Im-H5), 7.04 (1H, s, Im-H4), 7.58 (1H, s, Im-H2) and 8.38 ppm (1H, m, Ar—H2); δC(CDCl3) CH3: 28.3/28.4, 28.3/28.4, 28.3/28.4; CH2: 18.9, 24.9/25.0/25.5, 26.8, 30.2, 30.5, 36.2, 40.1, 42.7/43.0, 46.5/46.7, 50.1/50.3/50.7, 52.7/52.9; CH: 46.9, 51.6/52.0, 78.5, 119.0, 126.2/126.3, 128.6, 130.8/130.9, 132.6, 137.0, 141.5, 146.9/147.2; C: 80.2, ˜120.1, 134.3, 134.9, 137.6, 140.8, ˜155.1/156.1, ˜156.8, ˜170.3.

Sources & evidence

ORD record
ord-d913cf37f5ad4b909a2ad1566c2bd0c6
Source dataset
uspto-grants-2004_10
Patent number
US06800636B2

Reaction notes

Loading…